{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:05:35Z","timestamp":1784081135108,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Cancer Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04559-z","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:24:19Z","timestamp":1779355459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological characteristics and prognostic analysis of synchronous endometrioid endometrial and ovarian carcinomas: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanhua","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"4559_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijscr.2017.10.034","volume":"41","author":"L Tashima","year":"2017","unstructured":"Tashima L, Hori K, Ono H, Nagano T, Nakatsuka SI, Ito K. Endometrioid adenocarcinoma originating simultaneously from endometrium, sites of adenomyosis and ovarian endometriosis: a case report and review of our cancer database. Int J Surg Case Rep. 2017;41:226\u20139.","journal-title":"Int J Surg Case Rep"},{"key":"4559_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12905-022-01917-5","volume":"22","author":"A Ishizaka","year":"2022","unstructured":"Ishizaka A, Taguchi A, Tsuruga T, Maruyama M, Kawata A, Miyamoto Y, et al. Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study. BMC Womens Health. 2022;22:332.","journal-title":"BMC Womens Health"},{"key":"4559_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/ijgc-00009577-200801000-00026","volume":"18","author":"YC Chiang","year":"2008","unstructured":"Chiang YC, Chen CA, Huang CY, Hsieh CY, Cheng WF. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer. 2008;18:159\u201364.","journal-title":"Int J Gynecol Cancer"},{"key":"4559_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/gyno.2001.6400","volume":"83","author":"R Zaino","year":"2001","unstructured":"Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83:355\u201362.","journal-title":"Gynecol Oncol"},{"key":"4559_CR5","doi-asserted-by":"crossref","unstructured":"Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Washington DC: Atlas of Tumor Pathology, Armed Forces Institute of Pathology\/American Registry of Pathology; 1998.","DOI":"10.1097\/00004347-199907000-00019"},{"key":"4559_CR6","doi-asserted-by":"publisher","first-page":"djv427","DOI":"10.1093\/jnci\/djv427","volume":"108","author":"AM Schultheis","year":"2016","unstructured":"Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, et al. Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas. J Natl Cancer Inst. 2016;108:djv427.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"4559_CR7","doi-asserted-by":"publisher","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","volume":"108","author":"MS Anglesio","year":"2016","unstructured":"Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J, et al. Synchronous endometrial and ovarian carcinomas: evidence of clonality. J Natl Cancer Inst. 2016;108(6):djv428.","journal-title":"J Natl Cancer Inst"},{"key":"4559_CR8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41379-020-00721-6","volume":"34","author":"LA Moukarzel","year":"2021","unstructured":"Moukarzel LA, Da Cruz PA, Ferrando L, Hoang T, Sebastiao APM, Pareja F, et al. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes. Mod Pathol. 2021;34:994\u20131007.","journal-title":"Mod Pathol"},{"key":"4559_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/his.13985","volume":"76","author":"L Casey","year":"2020","unstructured":"Casey L, Singh N. Metastases to the ovary arising from endometrial, cervical and Fallopian tube cancer: recent advances. Histopathology. 2020;76:37\u201351.","journal-title":"Histopathology"},{"key":"4559_CR10","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","volume":"34","author":"JS Berek","year":"2023","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al. FIGO staging of endometrial cancer: 2023. J Gynecol Oncol. 2023;34:e85.","journal-title":"J Gynecol Oncol"},{"key":"4559_CR11","doi-asserted-by":"publisher","first-page":"113533","DOI":"10.1016\/j.ejca.2024.113533","volume":"200","author":"K Matsuo","year":"2024","unstructured":"Matsuo K, Chen L, Neuman MK, Klar M, Roman LD, Wright JD. Low-grade endometrioid endometrial cancer with adnexal only metastasis: evaluation of de-escalation of adjuvant therapy. Eur J Cancer. 2024;200:113533.","journal-title":"Eur J Cancer"},{"key":"4559_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1757-2215-6-59","volume":"6","author":"D Atallah","year":"2013","unstructured":"Atallah D, Safi J, El Kassis N, Rouzier R, Chahine G. Simultaneous early ovarian and endometrial cancer treated conservatively with spontaneous pregnancy. J Ovarian Res. 2013;6:59.","journal-title":"J Ovarian Res"},{"key":"4559_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, et al. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res. 2016;2:247\u201358.","journal-title":"J Pathol Clin Res"},{"key":"4559_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/PGP.0000000000000538","volume":"38","author":"J Magrill","year":"2019","unstructured":"Magrill J, Karnezis AN, Tessier-Cloutier B, Talhouk A, Kommoss S, Cochrane D, et al. Tubo-ovarian transitional cell carcinoma and high-grade serous carcinoma show subtly different immunohistochemistry profiles. Int J Gynecol Pathol. 2019;38:552\u201361.","journal-title":"Int J Gynecol Pathol"},{"key":"4559_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00428-022-03390-9","volume":"481","author":"Y Bai","year":"2022","unstructured":"Bai Y, Guo T, Niu D, Zhu Y, Ren W, Yao Q, et al. Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population. Virchows Arch. 2022;481:903\u201311.","journal-title":"Virchows Arch"},{"key":"4559_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.5858\/arpa.2016-0331-CP","volume":"140","author":"AN Bartley","year":"2016","unstructured":"Bartley AN, Washington MK, Ventura CB, Ismaila N, Colasacco C, Benson AB, et al. HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Arch Pathol Lab Med. 2016;140:1345\u201363.","journal-title":"Arch Pathol Lab Med"},{"key":"4559_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/01443615.2014.960827","volume":"35","author":"M Dogan Altunpulluk","year":"2016","unstructured":"Dogan Altunpulluk M, Kir G, Topal CS, Cetiner H, Gocmen A. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis. J Obstet Gynaecol. 2016;35:397\u2013402.","journal-title":"J Obstet Gynaecol"},{"key":"4559_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ygyno.2016.07.114","volume":"143","author":"A Chao","year":"2016","unstructured":"Chao A, Wu RC, Jung SM, Lee YS, Chen SJ, Lu YL, et al. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology. Gynecol Oncol. 2016;143:60\u20137.","journal-title":"Gynecol Oncol"},{"key":"4559_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12885-017-3054-6","volume":"17","author":"N Valtcheva","year":"2017","unstructured":"Valtcheva N, Lang FM, Noske A, Samartzis EP, Schmidt AM, Bellini E, et al. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. BMC Cancer. 2017;17:66.","journal-title":"BMC Cancer"},{"key":"4559_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ygyno.2024.04.016","volume":"187","author":"K Matsuo","year":"2024","unstructured":"Matsuo K, Chen L, Klar M, Lee MW, Machida H, Mikami M, et al. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer. Gynecol Oncol. 2024;187:37\u201345.","journal-title":"Gynecol Oncol"},{"key":"4559_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12885-024-12633-8","volume":"24","author":"C Yu","year":"2024","unstructured":"Yu C, Yuan X, Yao Q, Xu Y, Zhou X, Hu X, et al. Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort. BMC Cancer. 2024;24:862.","journal-title":"BMC Cancer"},{"key":"4559_CR22","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","volume":"51","author":"T Bosse","year":"2015","unstructured":"Bosse T, Peters EE, Creutzberg CL, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Mens JW, et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer. 2015;51:1742\u201350.","journal-title":"Eur J Cancer"},{"key":"4559_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ygyno.2017.07.119","volume":"147","author":"Y Qian","year":"2017","unstructured":"Qian Y, Pollom EL, Nwachukwu C, Seiger K, von Eyben R, Folkins AK, et al. Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. Gynecol Oncol. 2017;147:24\u20139.","journal-title":"Gynecol Oncol"},{"key":"4559_CR24","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","volume":"22","author":"E Stelloo","year":"2016","unstructured":"Stelloo E, Nout RA, Osse EM, J\u00fcrgenliemk-Schulz IJ, Jobsen JJ, Lutgens LC, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin Cancer Res. 2016;22:4215\u201324.","journal-title":"Clin Cancer Res"},{"key":"4559_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S, Li-Chang HH, Kwon JS, Melnyk N, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113:299\u2013310.","journal-title":"Br J Cancer"},{"key":"4559_CR26","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1200\/JCO.20.00549","volume":"38","author":"A Le\u00f3n-Castillo","year":"2020","unstructured":"Le\u00f3n-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, et al. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. J Clin Oncol. 2020;38:3388\u201397.","journal-title":"J Clin Oncol"},{"key":"4559_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/his.12934","volume":"69","author":"PF Rambau","year":"2016","unstructured":"Rambau PF, Duggan MA, Ghatage P, Warfa K, Steed H, Perrier R, et al. Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Histopathology. 2016;69:288\u201397.","journal-title":"Histopathology"},{"key":"4559_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAS.0000000000001165","volume":"43","author":"JA Bennett","year":"2019","unstructured":"Bennett JA, Pesci A, Morales-Oyarvide V, Da Silva A, Nardi V, Oliva E. Incidence of mismatch repair protein deficiency and associated clinicopathologic features in a cohort of 104 ovarian endometrioid carcinomas. Am J Surg Pathol. 2019;43:235\u201343.","journal-title":"Am J Surg Pathol"},{"key":"4559_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","volume":"94","author":"PT Soliman","year":"2004","unstructured":"Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456\u201362.","journal-title":"Gynecol Oncol"},{"key":"4559_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","volume":"36","author":"A Aysal","year":"2012","unstructured":"Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012;36:163\u201372.","journal-title":"Am J Surg Pathol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04559-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04559-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04559-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:53:15Z","timestamp":1784080395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04559-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4559"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04559-z","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Peking University Cancer Hospital & Institute (Permission number 2024YJZ145). Additional patient consent for this retrospective study was waived by approval of the ethics committee. All procedures were conducted in accordance with the Declaration of Helsinki and relevant ethical regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"358"}}